GIM27-THERapy: a Study to Describe the Effectiveness of Tucatinib in Combination With Capecitabine and Trastuzumab in the Treatment of Metastatic HER-2 Positive Breast Cancer Patients in Real World Setting
Clinical trial NCT07583485 · RECRUITING
Trial details
- NCT number
- NCT07583485
- Sponsor
- Fondazione Oncotech
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-01
- Primary completion
- 2029-07-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.